Shandong Wohua Pharmaceutical Co Ltd (002107) - Total Liabilities
Based on the latest financial reports, Shandong Wohua Pharmaceutical Co Ltd (002107) has total liabilities worth CN¥256.47 Million CNY (≈ $37.53 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Shandong Wohua Pharmaceutical Co Ltd (002107) cash conversion ratio to assess how effectively this company generates cash.
Shandong Wohua Pharmaceutical Co Ltd - Total Liabilities Trend (2003–2025)
This chart illustrates how Shandong Wohua Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Shandong Wohua Pharmaceutical Co Ltd (002107) shareholders funds for net asset value and shareholders' equity analysis.
Shandong Wohua Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Shandong Wohua Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Energy Resources of Australia Ltd
AU:ERA
|
Australia | AU$2.34 Billion |
|
Daewoong
KO:003090
|
Korea | ₩1.47 Trillion |
|
Korea District Heating Corp
KO:071320
|
Korea | ₩5.68 Trillion |
|
Shanghai Metersbonwe Fashion&Accessories Co Ltd
SHE:002269
|
China | CN¥1.60 Billion |
|
Taiwan Sakura Corp
TW:9911
|
Taiwan | NT$4.04 Billion |
|
TA-I Technology Co Ltd
TW:2478
|
Taiwan | NT$3.02 Billion |
|
Akfen Yenilenebilir Enerji A.S.
IS:AKFYE
|
Turkey | TL16.84 Billion |
|
iHeartMedia Inc Class A
NASDAQ:IHRT
|
USA | $7.43 Billion |
Liability Composition Analysis (2003–2025)
This chart breaks down Shandong Wohua Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 002107 market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.35 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.35 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shandong Wohua Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shandong Wohua Pharmaceutical Co Ltd (2003–2025)
The table below shows the annual total liabilities of Shandong Wohua Pharmaceutical Co Ltd from 2003 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥256.47 Million ≈ $37.53 Million |
-2.41% |
| 2024-12-31 | CN¥262.80 Million ≈ $38.46 Million |
-15.56% |
| 2023-12-31 | CN¥311.23 Million ≈ $45.54 Million |
+0.33% |
| 2022-12-31 | CN¥310.20 Million ≈ $45.39 Million |
+33.81% |
| 2021-12-31 | CN¥231.83 Million ≈ $33.92 Million |
-48.72% |
| 2020-12-31 | CN¥452.08 Million ≈ $66.15 Million |
+94.13% |
| 2019-12-31 | CN¥232.87 Million ≈ $34.08 Million |
+2.77% |
| 2018-12-31 | CN¥226.60 Million ≈ $33.16 Million |
+13.46% |
| 2017-12-31 | CN¥199.71 Million ≈ $29.22 Million |
+50.17% |
| 2016-12-31 | CN¥132.99 Million ≈ $19.46 Million |
+9.94% |
| 2015-12-31 | CN¥120.97 Million ≈ $17.70 Million |
+227.89% |
| 2014-12-31 | CN¥36.89 Million ≈ $5.40 Million |
-7.79% |
| 2013-12-31 | CN¥40.01 Million ≈ $5.85 Million |
-18.81% |
| 2012-12-31 | CN¥49.28 Million ≈ $7.21 Million |
+35.86% |
| 2011-12-31 | CN¥36.28 Million ≈ $5.31 Million |
-20.26% |
| 2010-12-31 | CN¥45.49 Million ≈ $6.66 Million |
-46.73% |
| 2009-12-31 | CN¥85.41 Million ≈ $12.50 Million |
+15.06% |
| 2008-12-31 | CN¥74.23 Million ≈ $10.86 Million |
-32.71% |
| 2007-12-31 | CN¥110.32 Million ≈ $16.14 Million |
+16.81% |
| 2006-12-31 | CN¥94.44 Million ≈ $13.82 Million |
+12.59% |
| 2005-12-31 | CN¥83.88 Million ≈ $12.27 Million |
+19.33% |
| 2004-12-31 | CN¥70.30 Million ≈ $10.29 Million |
-15.59% |
| 2003-12-31 | CN¥83.28 Million ≈ $12.19 Million |
-- |
About Shandong Wohua Pharmaceutical Co Ltd
Shandong Wohua Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in China. The company produces and sells tablets, granules, capsules, oral liquid, and pills; medicinal herb cultivation; and provides pharmaceutical technology consulting services. It also offers products including drugs for cardiovascular, cerebrovascular, and nervous system diseases, such as Wohua Xinkeshu t… Read more